[Diagnosis and treatment of vascular dementia]

Markus A Hobert1, Werner Hofmann2,3, Thorsten Bartsch4

  • 1Klinik für Neurologie, Christian-Albrechts-University zu Kiel, Kiel, Deutschland. Markus.Hobert@uksh.de.

Insights

Vascular dementias (VD), the second most common dementia type, impact geriatric patients. This review covers VD causes, clinical and radiological findings, and emphasizes education, prevention, and rehabilitation strategies.

Area of Science:

  • Neurology
  • Geriatrics
  • Radiology

Background:

  • Vascular dementias (VD) are the second leading cause of dementia, prevalent in geriatric populations.
  • VD can result from acute events like stroke or chronic cerebrovascular damage.
  • This review specifically addresses VD linked to infarcts and intracerebral bleeding.

Purpose of the Study:

  • To provide a comprehensive overview of vascular dementias.
  • To detail clinical and radiological characteristics of VD.
  • To highlight the importance of education, prevention, and rehabilitation in managing VD.

Main Methods:

  • Literature review focusing on vascular dementia.
  • Analysis of clinical presentations and radiological findings.
  • Synthesis of information on educational, preventive, and rehabilitative interventions.

Main Results:

  • Vascular dementias encompass various etiologies, including strategic infarcts, lacunar infarcts, and intracerebral hemorrhage.
  • Clinical manifestations and diagnostic imaging are crucial for identifying VD.
  • Effective management strategies involve patient education, preventative measures, and rehabilitation programs.

Conclusions:

  • Vascular dementias are a significant health concern, particularly in the elderly.
  • A multi-faceted approach combining clinical understanding, radiological diagnosis, and proactive management is essential for addressing VD.
  • Emphasis on education, prevention, and rehabilitation can improve outcomes for individuals with vascular dementia.

Related Concept Videos

Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
634
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
410
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
213
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.4K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
295
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
223